Sub-Saharan Africa is facing a dearth of vaccines and will be reliant in 2021 on external vaccine supply, particularly through pooled procurement schemes. The WHO estimates that, at best, 30-35% of Africa's 1.3 billion population could be vaccinated in 2021. This slow rollout will result in strict lock-down measures and the economic knock-on effects will be felt across the region. In this episode, our economics and risk teams discuss everything from vaccine supply and rollout timelines. economic implications and recovery efforts, and finally vaccine diplomacy. For a deeper dive, read our latest blog: The geopolitical implications of vaccine rollout programs across Sub-Saharan Africa https://ihsmarkit.com/research-analysis/geopolitical-implications-vaccine-rollout-sub-saharan-africa.html Lindsay Newman, Director, Economics & Country Risk, IHS Markit https://ihsmarkit.com/experts/newman-lindsay.html Thea Fourie, Associate Director, Sub-Saharan Africa Economics, IHS Markit https://ihsmarkit.com/experts/fourie-thea.html William Farmer, Analyst, Sub-Saharan Africa, Country Risk, IHS Markithttps://ihsmarkit.com/experts/farmer-william.html

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.